Healthcare · Medical Devices
$6.31
−$0.47−6.93%
Delayed · · marketstack
−$6.89−52.20%over 1M
Price ÷ trailing earnings
No comments yet
Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.
Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.
Updated · the last close
What AEMD has filed with the SEC. This is not Aethlon Medical Inc.’s own investor relations site: these filings are the primary source that site publishes from.
Also filed under Medical Devices, ranked by how closely they sit beside AEMD.
From Item 1A of its most recent 10-K, filed June 2026.
And 14 more.
FDA approval
We have not received the required FDA approval of our IDE supplement for a new qualified supplier of the GNA and are working with the FDA to gain approval of this supplier. Although we have resumed purchasing GNA from our prior supplier, it is possible that …7 more themes are on Measure
Free, no card, and it does not expire. See what the paid plans add
The assistant answers from what AEMD has actually filed: 16 annual reports filed with the SEC and 16 Form 4 filings from the last year. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.
Press one and the answer appears right here on the page, from AEMD's filings and figures. One a day without an account; a free account has its own, and no card.
See how much of Aethlon Medical Inc. each of these investors holds, and every quarter they moved.
Ten seconds. No card. Nothing to cancel.
Be told the moment a AEMD insider trades
Put Aethlon Medical Inc. on a watchlist for a free alert, the bell and a daily email, when a Form 4 worth a row is filed, with vesting and automatic tax sales already struck out so what lands is a decision, not paperwork.
The full filing historyMeasure
Ask what growth the price is already betting on
Aethlon Medical Inc.'s income statement, balance sheet and cash flow as filed, and the ratios computed from them, plus a reverse DCF that holds today's price fixed and solves for the growth it requires.
The reverse DCFMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: how big a bet each one is, and by how much it changed.
Every position, sizedMeasure
Interrogate the filing, not the internet
Ask anything about Aethlon Medical Inc.'s fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.
Free, no card, and it does not expire.
27 more events are on Measure
Free, no card, and it does not expire. See what the paid plans add
Out of 600 passages in this year’s Item 1A.
New this year
221 more passages are on Bespoke
Free, no card, and it does not expire. See what the paid plans add